Provided by Tiger Fintech (Singapore) Pte. Ltd.

Artivion

23.17
-0.5200-2.20%
Volume:164.26K
Turnover:3.82M
Market Cap:989.11M
PE:-72.41
High:23.72
Open:23.72
Low:23.04
Close:23.69
Loading ...

Should You Investigate Artivion, Inc. (NYSE:AORT) At US$28.26?

Simply Wall St.
·
25 Feb

Artivion Inc expected to post a loss of 6 cents a share - Earnings Preview

Reuters
·
22 Feb

Artivion (NYSE:AORT) Q3 Earnings: Leading The Medical Devices & Supplies - Cardiology, Neurology, Vascular Pack

StockStory
·
14 Feb

Spotting Winners: Penumbra (NYSE:PEN) And Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks In Q3

StockStory
·
13 Feb

Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2024 Financial Results

PR Newswire
·
11 Feb

Sensus Healthcare (SRTS) Moves 19.9% Higher: Will This Strength Last?

Zacks
·
03 Feb

Artivion Receives Buy Rating from Michael Matson Following Promising Clinical Trial Results and Market Expansion Opportunities

TIPRANKS
·
28 Jan

Positive Trial Data and FDA Prospects Drive Buy Rating for Artivion

TIPRANKS
·
28 Jan

Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 61st Society of Thoracic Surgery Annual Meeting

PR Newswire
·
27 Jan

3 US Stocks Estimated To Be Trading Below Their Intrinsic Value In January 2025

Simply Wall St.
·
14 Jan

Artivion (AORT) Gets a Buy from Lake Street

TIPRANKS
·
06 Jan

Artivion Price Target Maintained With a $34.00/Share by Needham

Dow Jones
·
10 Dec 2024

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Artivion (AORT) and Revance Therapeutics (RVNC)

TIPRANKS
·
10 Dec 2024

Artivion Receives FDA Humanitarian Device Exemption for AMDS Hybrid Prosthesis

MT Newswires Live
·
10 Dec 2024

Artivion reports hackers stole files during cybersecurity incident

TIPRANKS
·
10 Dec 2024

BRIEF-Artivion Granted FDA Humanitarian Device Exemption For The AMDS Hybrid Prosthesis

Reuters
·
09 Dec 2024

Artivion Granted FDA Humanitarian Device Exemption for the Amds Hybrid Prosthesis

THOMSON REUTERS
·
09 Dec 2024

Artivion Inc: Continue to Work Towards Pma Approval, Which We Still Expect in Late 2025

THOMSON REUTERS
·
09 Dec 2024

Artivion Granted FDA Humanitarian Device Exemption for the AMDS Hybrid Prosthesis

PR Newswire
·
09 Dec 2024

Artivion Restoring Systems After Cyberattack

Dow Jones
·
09 Dec 2024